Effects of transdermal nicotine patches on ambulatory ECG monitoring findings: A double-blind study in healthy smokers

Cardiovascular Drugs and Therapy

Volumn 10, Issue 2, 1996, Pages 179-184

  Khoury, Zahi ^a   Comans, Phillip ^b   Keren, Andre ^a   Lerer, Tuvia ^c   Gavish, Alex ^a   Tzivoni, Dan ^d  

^a BIKUR CHOLIM HOSPITAL   (Israel)

^b CIBA GEIGY LTD   (Switzerland)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Ambulatory ECG; Arrhythmia; Healthy subjects; Nicotine patches; Smoking; Smoking cessation

Indexed keywords

CARBON MONOXIDE; COTININE; NICOTINE;

ABDOMINAL PAIN; ADULT; AMBULATORY MONITORING; ARTICLE; BEHAVIOR THERAPY; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE; TRANSDERMAL DRUG ADMINISTRATION; URINE LEVEL;

ADMINISTRATION, CUTANEOUS; ADULT; BLOOD PRESSURE; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NICOTINE; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0029999308     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00823596     Document Type: Article

References (35)

1. Jonas MA, Oates JA, Ockene JK, Hennekens CH. AHA Medical/Scientific Statement. Position Statement: Statement on smoking and cardiovascular disease for health care professions. Circulation 1992;86:1664-1669.
2. US Department of Health and Human Services. Reducing the Health Consequences of Smoking. At 25 Years of Progress. A Report of the Surgeon-General. USDHMS, Public Health Service, Centers for Disease Control, Office of Smoking and Health, DMHS publication no (CDC) 89-8411, 1989.
3. Bellet S, DeGuzman NT, Kostis JB, Roman L, Fleischmann D. The effect of inhalation of cigarette smoke on ventricular fibrillation threshold in normal dogs with acute myocardial infarction. A Heart J 1972;83:67-76.
4. Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrences of sudden cardiac arrest. N Engl J Med 1989;314:271-275.
5. Zhu B, Sun Y, Sievers RE, Glantz SA, Parmley WW, Wolfe CL. Exposure to environmental tobacco smoke increases myocardial infact size in rats. Circulation 1994;89: 1282-1290.
6. Nicod P, Rehr R, Winniford MD, Campbell WB, Firth BG, Hillis LD. Acute systemic and coronary hemodynamic and serologic responses to cigarette smoking in long-term smokers with atherosclerotic coronary artery disease. J Am Coll Cardiol 1984;4:964-971.
7. Volosin KJ, Brachfeld C, Beauregard LA, Fabiszewski F, Waxman HL. Effect of cigarette smoke on sinus mode automaticity. Am J Cardiol 1990;65:243-245.
8. Moreyra AE, Lacy CR, Wilson AC, Kumar A, Kostis JB. Arterial blood nicotine concentration and coronary vasoconstrictive effect of low-nicotine cigarette smoking. Am Heart J 1992;124:392-397.
9. Hayano J, Yamada M, Sakakibara Y, et al. Short and long terms effects of cigarette smoking on heart rate variability. Am J Cardiol 1990;65:84-88.
10. Winniford MD, Wheelan KR, Kremers MS, et al. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: Evidence of adrenergically mediated alteration in coronary artery tone. Circulation 1986;73:662-667.
11. Winniford MD, Jansen DE, Reynolds GA, Appril P, Black WH, Hillis HD. Cigarette smoking-induced coronary vasoconstriction in atherosclerotic coronary artery disease and prevention by calcium antagonists and nitroglycerin. Am J Cardiol 1987;59:203-207.
12. Nitenberg A, Antony I, Foult JM. Acetylcholine induces constriction of normal coronary arteries in young heavy smokers (abstr). Circulation 1992;86:I-158.
13. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993;87:76-79.
14. Aronow W. Effect of passive smoking on angina pectoris. N Engl J Med 1978;299:21-24.
15. Nyboe J, Jensen G, Appleyard M, Schnohr P. Smoking and the risk of first acute myocardial infarction. Am Heart J 1991;122:438-447.
16. Fagerstrom KO. Measuring the degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978;3:235-241.
17. Rose JE, Herskovic JE, Trilling Y, Jarvis ME. Transdermal nicotine reduces cigarette craving and nicotine preference. Clin Pharmacol Ther 1985;38:450-456.
18. Abelin T, Ehrsam R, Buhler-Reichert A, et al. Effectiveness of a transdermal nicotine system in smoking cessation studies. Methods Exp Clin Pharmacol 1989;11:205-214.
19. Abelin T, Buhler-Reichert A, Muller P, Vesanen K, Imhof PR. Controlled trial transdermal patch in tobacco withdrawal. Lancet 1989;8628:7-10.
20. West JJ Hajek P, Belcher M. Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol Med 1989;19:981-985.
21. Tonnesen P, Norregaard J, Simonsen K, Sawe U. A double-blind trial of a 16-hour transdermal nicotine cessation. N Engl J Med 1991;325:311-315.
22. Sutherland G, Stapleton JA, Russell MA, et al. Randomized controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992;340:324-329.
23. Fiore MC, Jorenby DE, Baker TB, Kenford SL. Tobacco dependence and the nicotine patch. JAMA 1992;268: 2687-2694.
24. Tang JL, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? Br Med J 1994;308:21-26.
25. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994;343:139-142.
26. Draize JH, Woodward G, Calvery HO. Methods of the study of initiation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 1944;82:377-419.
27. Jarvis M, Russel M, Saloojee Y. Expired air carbon monoxide: a simple breath test of tobacco smoke intake. Br Med J 1980;281:484-5.
28. Sioufi A, Parisot C, Sandrenan N, Dubois JP. High performance liquid chromatographic determination of nicotine and cotinine, simultaneously in urine. Methods Find Exp Clin Pharmacol 1989;11:179-185.
29. Ikard FF, Green DE, Horn D. A scale to differentiate between types of smoking as related to the management of effect. Int J Addict 1969;4:649-650.
30. Imperial Cancer Research Fund General Practice Research Group. Effectiveness of a nicotine patch in helping people stop smoking: Results of a randomized trial in general practice. Br Med J 1993;306:1304-1308.
31. Russell MA, Stapleton JA, Feyerabend C, et al. Targeting heavy smokers in general practice: Randomized controlled trial of transdermal nicotine patches. Br Med J 1993;306: 1308-1312.
32. Daughton DM, Scott A, Heatley A, et al. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. Arch Intern Med 1991;151: 749-752.
33. Nobuyoshi M, Abe M, Nosaka H, et al. Statistical analysis of clinical risk factors for coronary spasm: Indentification of the most important determinant. Am Heart J 1992;124: 32-38.
34. Jackson M. Cerebral artery narrowing with nicotine patch (correspondence). Lancet 1993;324:236-237.
35. Rennard S, Daughton D, Fortman S, et al. Transdermal nicotine enhances smoking cessation in coronary artery disease patients. Chest 1991;100:5S.